Business Description
Mabwell (Shanghai) Bioscience Co Ltd
ISIN : CNE100005RD2
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.73 | |||||
Equity-to-Asset | 0.43 | |||||
Debt-to-Equity | 1.14 | |||||
Debt-to-EBITDA | -2.12 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 0.25 | |||||
Beneish M-Score | -2.22 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 156.3 | |||||
3-Year EBITDA Growth Rate | -4.5 | |||||
3-Year EPS without NRI Growth Rate | -5.6 | |||||
3-Year FCF Growth Rate | -12.3 | |||||
3-Year Book Growth Rate | 9.6 | |||||
Future 3-5Y EPS without NRI Growth Rate | 48.9 | |||||
Future 3-5Y Total Revenue Growth Rate | 122.57 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 61.52 | |||||
9-Day RSI | 56.24 | |||||
14-Day RSI | 53.81 | |||||
6-1 Month Momentum % | -24.19 | |||||
12-1 Month Momentum % | -14.8 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.4 | |||||
Quick Ratio | 1.25 | |||||
Cash Ratio | 1.1 | |||||
Days Inventory | 5347.49 | |||||
Days Sales Outstanding | 52.62 | |||||
Days Payable | 1899.18 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -10.1 | |||||
Shareholder Yield % | -8.97 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 93.15 | |||||
Operating Margin % | -608.7 | |||||
Net Margin % | -634.07 | |||||
FCF Margin % | -680.58 | |||||
ROE % | -44.77 | |||||
ROA % | -23.76 | |||||
ROIC % | -34.06 | |||||
ROC (Joel Greenblatt) % | -53.58 | |||||
ROCE % | -29.24 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 58.26 | |||||
PB Ratio | 5.14 | |||||
Price-to-Tangible-Book | 5.95 | |||||
EV-to-EBIT | -10.13 | |||||
EV-to-EBITDA | -10.13 | |||||
EV-to-Revenue | 61.54 | |||||
EV-to-FCF | -8.77 | |||||
Earnings Yield (Greenblatt) % | -9.87 | |||||
FCF Yield % | -11.73 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Mabwell (Shanghai) Bioscience Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 169.42 | ||
EPS (TTM) (Â¥) | -2.7 | ||
Beta | 0 | ||
Volatility % | 56.55 | ||
14-Day RSI | 53.81 | ||
14-Day ATR (Â¥) | 1.466345 | ||
20-Day SMA (Â¥) | 23.4815 | ||
12-1 Month Momentum % | -14.8 | ||
52-Week Range (Â¥) | 19.9 - 37 | ||
Shares Outstanding (Mil) | 399.6 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Mabwell (Shanghai) Bioscience Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Mabwell (Shanghai) Bioscience Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Mabwell (Shanghai) Bioscience Co Ltd Frequently Asked Questions
What is Mabwell (Shanghai) Bioscience Co Ltd(SHSE:688062)'s stock price today?
When is next earnings date of Mabwell (Shanghai) Bioscience Co Ltd(SHSE:688062)?
Does Mabwell (Shanghai) Bioscience Co Ltd(SHSE:688062) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |